OTC Markets OTCQB - Delayed Quote USD
Hemostemix Inc. (HMTXF)
0.0640
0.0000
(0.00%)
As of April 24 at 4:00:00 PM EDT. Market Open.
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 0 | 0 |
| Sales | -- | 0 |
| Net Shares Purchased (Sold) | 0 | 0 |
| Total Insider Shares Held | 12.27M | -- |
| % Net Shares Purchased (Sold) | -- | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| Smeenk, Thomas Director of Issuer | Acquisition or disposition in the public market at price 0.07 per share. | Direct | 3,700 | Mar 25, 2025 |
| Smeenk, Thomas Director of Issuer | Acquisition or disposition in the public market at price 0.08 per share. | Direct | 3,850 | Mar 21, 2025 |
| Lacey (Peter Alan) Director of Issuer | Acquisition or disposition in the public market at price 0.11 per share. | Indirect | 12,906 | Mar 6, 2025 |
| Lacey (Peter Alan) Director of Issuer | Acquisition or disposition in the public market at price 0.10 per share. | Indirect | 21,000 | Mar 6, 2025 |
| Lacey (Peter Alan) Director of Issuer | Acquisition or disposition in the public market at price 0.10 per share. | Indirect | 613,600 | Mar 3, 2025 |
| Lacey (Peter Alan) Director of Issuer | Acquisition or disposition carried out privately at price 0.10 per share. | Indirect | 355,361 | Mar 3, 2025 |
| Lacey (Peter Alan) Director of Issuer | Acquisition or disposition carried out privately at price 0.10 per share. | Direct | 355,361 | Mar 3, 2025 |
| Lacey (Peter Alan) Director of Issuer | Acquisition or disposition in the public market at price 0.11 per share. | Indirect | 597,235 | Mar 3, 2025 |
| Lacey (Peter Alan) Director of Issuer | Acquisition or disposition in the public market at price 0.11 per share. | Indirect | 5,700 | Feb 28, 2025 |
| Lacey (Peter Alan) Director of Issuer | Acquisition or disposition in the public market at price 0.12 per share. | Indirect | 10,769 | Feb 27, 2025 |
| Lacey (Peter Alan) Director of Issuer | Acquisition or disposition in the public market at price 0.12 per share. | Indirect | 12,847 | Feb 27, 2025 |
| Lacey (Peter Alan) Director of Issuer | Acquisition or disposition in the public market at price 0.12 per share. | Direct | 11,768 | Feb 26, 2025 |
| Lacey (Peter Alan) Director of Issuer | Acquisition or disposition in the public market at price 0.12 per share. | Indirect | 24,400 | Feb 26, 2025 |
| Lacey (Peter Alan) Director of Issuer | Acquisition or disposition in the public market at price 0.12 per share. | Indirect | 3,450 | Feb 25, 2025 |
| Lacey (Peter Alan) Director of Issuer | Acquisition or disposition in the public market at price 0.12 per share. | Indirect | 17,250 | Feb 24, 2025 |
| Smeenk, Thomas Director of Issuer | Grant of options at price 0.19 per share. | Direct | 130,835 | Jan 22, 2025 |
| Smeenk, Thomas Director of Issuer | Compensation for services at price 0.07 per share. | Direct | 10,399 | Jan 8, 2025 |
| Lacey (Peter Alan) Director of Issuer | Compensation for services at price 0.07 per share. | Indirect | 239,185 | Jan 7, 2025 |
| Lacey (Peter Alan) Director of Issuer | Compensation for services at price 0.07 per share. | Indirect | 12,600 | Jan 7, 2025 |
| Smeenk, Thomas Director of Issuer | Acquisition or disposition carried out privately at price 0.04 per share. | Direct | 108,341 | Oct 31, 2024 |
| Swanberg (Loran) Director of Issuer | Acquisition or disposition under a purchase/ownership plan at price 0.04 per share. | Indirect | 14,400 | Oct 28, 2024 |
| Smeenk, Thomas Director of Issuer | Acquisition or disposition in the public market at price 0.05 per share. | Direct | 1,517 | Oct 18, 2024 |
| Smeenk, Thomas Director of Issuer | Acquisition or disposition in the public market at price 0.05 per share. | Direct | 8,670 | Oct 17, 2024 |
| Smeenk, Thomas Director of Issuer | Acquisition or disposition in the public market at price 0.05 per share. | Direct | 2,820 | Oct 16, 2024 |
| Smeenk, Thomas Director of Issuer | Acquisition or disposition in the public market at price 0.05 per share. | Direct | 3,576 | Oct 8, 2024 |
| Smeenk, Thomas Director of Issuer | Acquisition or disposition in the public market at price 0.05 per share. | Direct | 24,225 | Oct 7, 2024 |
| Smeenk, Thomas Director of Issuer | Acquisition or disposition in the public market at price 0.05 per share. | Direct | 15,555 | Oct 7, 2024 |
| Smeenk, Thomas Director of Issuer | Acquisition or disposition in the public market at price 0.05 per share. | Direct | 20,800 | Oct 4, 2024 |
| Smeenk, Thomas Director of Issuer | Acquisition or disposition in the public market at price 0.05 per share. | Direct | 15,600 | Oct 4, 2024 |
| Smeenk, Thomas Director of Issuer | Acquisition or disposition in the public market at price 0.03 per share. | Direct | 58 | Aug 21, 2024 |
| Smeenk, Thomas Director of Issuer | Acquisition or disposition in the public market at price 0.03 per share. | Direct | 290 | Jun 25, 2024 |
| Smeenk, Thomas Director of Issuer | Acquisition or disposition in the public market at price 0.03 per share. | Direct | 1,160 | May 1, 2024 |
Related Tickers
RENB Renovaro Inc.
0.3773
+1.21%
ONC BeiGene, Ltd.
247.27
-3.47%
RVPH Reviva Pharmaceuticals Holdings, Inc.
0.8172
-9.20%
APLT Applied Therapeutics, Inc.
0.4028
+1.13%
BMEA Biomea Fusion, Inc.
2.2450
-2.39%
BHVN Biohaven Ltd.
20.64
-11.82%
GERN Geron Corporation
1.4200
0.00%
REGN Regeneron Pharmaceuticals, Inc.
596.80
-0.49%
VRTX Vertex Pharmaceuticals Incorporated
491.52
-0.19%
MRNA Moderna, Inc.
27.35
-0.15%